Follow
R Lehloenya
R Lehloenya
Head of Dermatology, University of Cape Town
Verified email at uct.ac.za
Title
Cited by
Cited by
Year
Controversies in drug allergy: testing for delayed reactions
EJ Phillips, P Bigliardi, AJ Bircher, A Broyles, YS Chang, WH Chung, ...
Journal of Allergy and Clinical Immunology 143 (1), 66-73, 2019
1882019
SJS/TEN 2017: building multidisciplinary networks to drive science and translation
KD White, R Abe, M Ardern-Jones, T Beachkofsky, C Bouchard, ...
The Journal of Allergy and Clinical Immunology: In Practice 6 (1), 38-69, 2018
1642018
A dimorphic fungus causing disseminated infection in South Africa
C Kenyon, K Bonorchis, C Corcoran, G Meintjes, M Locketz, R Lehloenya, ...
New England Journal of Medicine 369 (15), 1416-1424, 2013
1472013
Severe delayed cutaneous and systemic reactions to drugs: a global perspective on the science and art of current practice
JG Peter, R Lehloenya, S Dlamini, K Risma, KD White, KC Konvinse, ...
The Journal of Allergy and Clinical Immunology: In Practice 5 (3), 547-563, 2017
1412017
Drug-associated adverse events and their relationship with outcomes in patients receiving treatment for extensively drug-resistant tuberculosis in South Africa
K Shean, E Streicher, E Pieterson, G Symons, R van Zyl Smit, G Theron, ...
PloS one 8 (5), e63057, 2013
1232013
Dermatologic manifestations of the immune reconstitution inflammatory syndrome
R Lehloenya, G Meintjes
Dermatologic clinics 24 (4), 549-570, 2006
1172006
Cutaneous adverse drug reactions to anti-tuberculosis drugs: state of the art and into the future
RJ Lehloenya, K Dheda
Expert review of anti-infective therapy 10 (4), 475-486, 2012
1022012
Clinical characteristics, diagnosis, management, and outcomes of disseminated emmonsiosis: a retrospective case series
IS Schwartz, NP Govender, C Corcoran, S Dlamini, H Prozesky, R Burton, ...
Clinical Infectious Diseases 61 (6), 1004-1012, 2015
822015
Outcomes of reintroducing anti-tuberculosis drugs following cutaneous adverse drug reactions
RJ Lehloenya, G Todd, M Badri, K Dheda
The International journal of tuberculosis and lung disease 15 (12), 1649-1657, 2011
712011
Drug hypersensitivity in HIV infection
J Peter, P Choshi, RJ Lehloenya
Current opinion in allergy and clinical immunology 19 (4), 272-282, 2019
592019
In vivo molecular dissection of the effects of HIV-1 in active tuberculosis
LCK Bell, G Pollara, M Pascoe, GS Tomlinson, RJ Lehloenya, J Roe, ...
PLoS pathogens 12 (3), e1005469, 2016
562016
SJS/TEN 2019: from science to translation
WC Chang, R Abe, P Anderson, W Anderson, MR Ardern-Jones, ...
Journal of dermatological science 98 (1), 2-12, 2020
512020
Diagnostic patch testing following tuberculosis‐associated cutaneous adverse drug reactions induces systemic reactions in HIV‐infected persons
RJ Lehloenya, G Todd, J Wallace, MR Ngwanya, R Muloiwa, K Dheda
British Journal of Dermatology 175 (1), 150-156, 2016
512016
AIDS-related endemic mycoses in Western Cape, South Africa, and clinical mimics: a cross-sectional study of adults with advanced HIV and recent-onset, widespread skin lesions
IS Schwartz, C Kenyon, R Lehloenya, S Claasens, Z Spengane, ...
Open forum infectious diseases 4 (4), ofx186, 2017
492017
Applications of immunopharmacogenomics: predicting, preventing, and understanding immune-mediated adverse drug reactions
JH Karnes, MA Miller, KD White, KC Konvinse, RK Pavlos, AJ Redwood, ...
Annual review of pharmacology and toxicology 59, 463-486, 2019
472019
Severe recurrence of drug rash with eosinophilia and systemic symptoms syndrome secondary to rifampicin patch testing in a human immunodeficiency virus‐infected man
K Shebe, MR Ngwanya, N Gantsho, RJ Lehloenya
Contact Dermatitis 70 (2), 125-127, 2014
432014
Transcriptional profiling of innate and adaptive human immune responses to mycobacteria in the tuberculin skin test
GS Tomlinson, TJ Cashmore, PTG Elkington, J Yates, RJ Lehloenya, ...
European Journal of Immunology 41 (11), 3253-3260, 2011
412011
Delabeling delayed drug hypersensitivity: how far can you safely go?
RJ Lehloenya, JG Peter, A Copascu, JA Trubiano, EJ Phillips
The Journal of Allergy and Clinical Immunology: In Practice 8 (9), 2878-2895. e6, 2020
362020
Factors associated with increased mortality in a predominantly HIV-infected population with Stevens Johnson syndrome and toxic epidermal necrolysis
L Knight, R Muloiwa, S Dlamini, RJ Lehloenya
PLoS One 9 (4), e93543, 2014
332014
Multiple drug hypersensitivity reactions to anti-tuberculosis drugs: five cases in HIV-infected patients
RJ Lehloenya, J Wallace, G Todd, K Dheda
The International journal of tuberculosis and lung disease 16 (9), 1260-1264, 2012
322012
The system can't perform the operation now. Try again later.
Articles 1–20